MedTrace Logo

Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous

NCT00481260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2009-09-04

No results posted yet for this study

Summary

Hgb C is an hemoglobinopathy quite rare in Israel. The clinical status of patients that are diagnosed as homozygous to this disease is quite benign but not study in large groups.

Also the characteristics of carriers and the incidence in northern Israel were a large arab population lives, was not study. The results of this study can be useful for screening purpose in a area were another hemoglobinopathies are frequent.

Conditions

  • Hgb C Hemoglobinopathy

Interventions

PROCEDURE

Medical history and basic laboratory analysis

Medical history and basic laboratory analysis

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Principal Investigators

  • Ariel Koren, MD · Pediatric Hematology Unit, Ha'Emek Medical Center

  • luci Zalman, Phd · Hematology Laboratory - HaeEmek Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00481260 on ClinicalTrials.gov